Lipoprotein(a) as a key target in combined therapeutic approaches for cardiovascular disease
Introduction and Objective: Lipoprotein(a) [Lp(a)] is an independent cardiovascular risk factor but is closely associated with other similar risk factors that are manageable with appropriate treatment and guidance. We aimed to study the impact of using combined therapy for managing Lp(a) levels in p...
Main Authors: | Joaquim A. Meireles Brandão, Lúcia R. Meireles-Brandão, Rui Coelho, Francisco Rocha-Gonçalves |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-07-01
|
Series: | Revista Portuguesa de Cardiologia |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0870255119304780 |
Similar Items
-
Lipoprotein(a) as a key target in combined therapeutic approaches for cardiovascular disease
by: Joaquim A. Meireles Brandão, et al.
Published: (2019-07-01) -
Lipoprotein(a) in the Evaluation of Cardiovascular Risk in the Portuguese Population
by: Joaquim A. Meireles-Brandão, et al.
Published: (2019-03-01) -
High-density lipoproteins: a novel therapeutic target for cardiovascular disease
by: TS Mohamed Saleem, et al.
Published: (2011-01-01) -
Lipoproteina (a) e risco vascular
by: Joaquim António Meireles Brandão
Published: (2021) -
Lipoprotein(a) as a novel therapeutic target for preventing cardiovascular disease: A whiter shade of pale?
by: Manuela Fiuza
Published: (2019-07-01)